Central neuropeptide B administration activates stress hormone secretion and stimulates feeding in male rats

Journal of Neuroendocrinology

Volumn 16, Issue 10, 2004, Pages 842-849

  Samson, Willis K ^a   Baker, J R ^a   Samson, C K ^a   Samson, H W ^a   Taylor, M M ^a  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Corticosterone; Growth hormone; Neuroendocrine; Pituitary; Prolactin

Indexed keywords

CORTICOSTERONE; CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; GROWTH HORMONE; GROWTH HORMONE RELEASING FACTOR; NEUROPEPTIDE; NEUROPEPTIDE B; OXYTOCIN; PROLACTIN; PROTIRELIN; UNCLASSIFIED DRUG; VASOPRESSIN;

ADENOHYPOPHYSIS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN VENTRICLE; CONCENTRATION RESPONSE; CORTICOSTERONE BLOOD LEVEL; FEEDING BEHAVIOR; GROWTH HORMONE BLOOD LEVEL; HORMONE ACTION; HORMONE INHIBITION; HORMONE RELEASE; IN VITRO STUDY; INCUBATION TIME; MALE; NEUROENDOCRINE SYSTEM; NONHUMAN; OXYTOCIN BLOOD LEVEL; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; RAT; SIGNAL TRANSDUCTION; VASOPRESSIN BLOOD LEVEL;

ADRENOCORTICOTROPIC HORMONE; ANIMALS; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; EATING; HORMONES; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; INJECTIONS, INTRAVENTRICULAR; MALE; NEUROPEPTIDES; NEUTRALIZATION TESTS; OXYTOCIN; PITUITARY GLAND, ANTERIOR; PROLACTIN; RADIOIMMUNOASSAY; RATS; RATS, SPRAGUE-DAWLEY; STIMULATION, CHEMICAL; STRESS, PSYCHOLOGICAL; VASOPRESSINS;

EID: 8544255552     PISSN: 09538194     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2826.2004.01239.x     Document Type: Article

References (19)

1. O'Dowd BF, Scheideler MA, Nguyen T, Cheng R, Rasmussen JS, Marchese A, Zastawny R, Heng HHQ, Tsui LC, Shi X, Asa S, Puy L, George SR. The cloning and chromosomal mapping of two novel human opioid-somatostatin-like receptor genes, GPR7 and GPR8, expressed in discrete areas of the brain. Genomics 1995; 28: 84-91.
2. Lee DK, Nguyen T, Porter CA, Cheng R, George SR, O'Dowd BF. Two related G protein-coupled receptors. the distribution of GPR7 in rat brain and the absence of GPR8 in rodents. Mol Brain Res 1999; 71: 96-103.
3. Fuji R, Yoshida H, Fukusumi S, Habata Y, Hosoya M, Kawamata Y, Yano T, Hunuma S, Kitada C, Asami T, Mori M, Fujisawa Y, Fujino M. Identification of a neuropeptide modified with bromine as an endogenous ligand for GPR7. J Biol Chem 2002; 277: 34010-34016.
4. Shimomura Y, Harada M, Goto M, Sugo T, Matsumoto Y, Abe M, Watanabe T, Asami T, Kitada C, Mori M, Onda H, Fujino M. Identification of neuropeptide W as the endogenous ligand for orphan G-protein coupled receptors GPR7 and GPR8. J Biol Chem 2002; 277: 35826-35832.
5. Tanaka H, Yoshida T, Miyamoto N, Motoike T, Kurosu H, Shibata K, Yamanaka A, Williams SC, Richardson JA, Tsujino N, Garry MG, Lerner MR, King DS, O'Dowd BF, Sakurai T, Yanagisawa M. Characterization of a family of endogenous neuropeptide ligands for the G protein-coupled receptors GPR7 and GPR8. Proc Natl Acad Sci USA 2003; 100: 6251-6256.
6. Baker JR, Cardinal K, Bober C, Taylor MM, Samson WK. Neuropeptide W acts in brain to control prolactin, corticosterone, and growth hormone release. Endocrinology 2003; 144: 2816-2821.
7. Mondal MS, Yamaguchi H, Date Y, Shmbara T, Toshinai H, Shimomura Y, Mori M, Nakazato M. A role for neuropeptide W in the regulation of feeding behaviour. Endocrinology 2003; 114: 4729-4733.
8. Samson WK, Said SI, Snyder GS, McGann SM. In vitro stimulation of prolactin release by vasoactive intestinal peptide. Peptide 1979; 1: 325-332.
9. Samson WK, Murphy TC, Resch ZT. Central mechanisms for the hypertensive effects of preproadrenomedullin-derived peptides in conscious rats. Am J Physiol 1998; 274: R1505-R1509.
10. Harms PG, Ojeda SR. A rapid and simple procedure for chronic cannulation of the rat jugular vein. J Appl Physiol 1974; 36: 391-392.
11. Ono N, Samson WK, McDonald JK, Lumpkin MD. Bedran de Castro JC, McCann SM. The effects of intravenous and intraventricular injection of antisera directed against corticotropin releasing factor (CRF) on the secretion of anterior pituitary hormones. Proc Natl Acad Sci USA 1985; 82: 7787-7790.
12. Samson WK, McDonald JK, Lumpkin MD. Naloxone dissociates stress-induced oxytocin and prolactin releases. Neuroendocrinology 1985; 40: 68-70.
13. Samson WK. Atrial natriuretic factor inhibits dehydration and hemorrhage-induced vasopressin release. Neuroendocrinology 1985; 40: 277-279.
14. Dun SL, Brailou GC, Yang J, Chang JK, Dun NJ. Neuropeptide W-immunoreactivity in the hypothalamus and pituitary of the rat. Neurosci Lett 2003; 349: 71-74.
15. Samson WK, Keown CA, Lane B, Samson CK, Samson HW, Taylor MM. Prolactin releasing peptide 31 and RFRP-1 act in hypothalamus to control stress hormone secretion. Endocrine 2003; 20: 59-66.
16. Ishii M, Fei H, Friedman JM. Targeted disruption of GPR7, the endogenous receptor for neuropeptides B and W, leads to metabolic defects and adult-onset obesity. Proc Natl Acad Sci USA 2003; 100: 10540-10545.
17. Ulrich-Lai YM, Engeland WC. Adrenal splanchnic innervation modulates adrenal cortical responses to dehydration stress in rats. Neuroendocrinology 2002; 76: 79-92.
18. Samson WK, Taylor MM, Folwell M, Ferguson AV. Orexin actions in hypothalamic paraventricular nucleus: physiologic consequences and cellular correlates. Regul Pept 2002; 104: 97-103.
19. Vale W, Vaughan J, Smith M, Yamamoto G, Rivier J, Rivier C. Effects of synthetic ovine corticotropin-releasing factor, glucocorticoids, catecholamines, neurohypophysial peptides, and other substances on cultured corticotropic cells. Endocrinology 1983; 113: 1121-1131.